HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bing Zou Selected Research

Chemoradiotherapy

5/2023Pneumonitis with combined immune checkpoint inhibitors and chemoradiotherapy in locally advanced non-small-cell lung cancer: a systematic review and meta-analysis.
7/2019Prognostic value of delta inflammatory biomarker-based nomograms in patients with inoperable locally advanced NSCLC.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bing Zou Research Topics

Disease

33Neoplasms (Cancer)
02/2024 - 11/2003
14Colonic Neoplasms (Colon Cancer)
01/2011 - 02/2005
12Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2024 - 07/2019
6Carcinogenesis
01/2011 - 11/2003
5Small Cell Lung Carcinoma (Small Cell Lung Cancer)
02/2024 - 01/2018
5Neoplasm Metastasis (Metastasis)
01/2023 - 01/2011
4Pneumonia (Pneumonitis)
02/2024 - 05/2021
4Esophageal Neoplasms (Esophageal Cancer)
08/2023 - 01/2020
4Inflammation (Inflammations)
06/2023 - 03/2009
4Stomach Neoplasms (Stomach Cancer)
09/2010 - 11/2003
4Gastrointestinal Neoplasms (Gastrointestinal Cancer)
09/2009 - 09/2006
3Hypoxia (Hypoxemia)
04/2022 - 10/2017
3Infections
01/2021 - 09/2009
2Sarcoidosis (Schaumann Disease)
08/2023 - 01/2020
2Radiation Pneumonitis
01/2023 - 05/2021
2Adenocarcinoma of Lung
01/2023 - 01/2022
2Shock
04/2021 - 02/2006
2Myocardial Infarction
01/2021 - 10/2016
2Nonsyndromic Deafness
01/2020 - 01/2017
2Carcinoma (Carcinomatosis)
01/2018 - 03/2006
2Ulcer
01/2017 - 10/2015
2Deafness (Deaf Mutism)
01/2017 - 01/2016
2Myocardial Ischemia (Ischemic Heart Diseases)
10/2016 - 01/2015
1Squamous Cell Neoplasms (Squamous Cell Cancer)
02/2024
1Thyroid Neoplasms (Thyroid Cancer)
01/2024
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
01/2024
1Mitochondrial Diseases (Mitochondrial Disease)
09/2023
1Esophageal Squamous Cell Carcinoma
08/2023
1Pulmonary Sarcoidosis
08/2023
1Sepsis (Septicemia)
06/2023
1Lymphopenia (Lymphocytopenia)
06/2023
1Colitis
02/2023
1Drug Resistant Epilepsy
01/2023
1Cardiac Arrhythmias (Arrythmia)
04/2022
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022
1Thymoma (Thymic Carcinoma)
01/2022
1Esophagitis
05/2021
1Hypertension (High Blood Pressure)
04/2021
1Nephrolithiasis
04/2021
1Urolithiasis
04/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2021
1Autoimmune Diseases (Autoimmune Disease)
11/2020

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
10/2017 - 03/2006
8Immune Checkpoint InhibitorsIBA
02/2024 - 01/2021
8LigandsIBA
03/2010 - 06/2008
7X-Linked Inhibitor of Apoptosis ProteinIBA
10/2012 - 03/2006
6Biomarkers (Surrogate Marker)IBA
01/2024 - 01/2018
5PPAR gammaIBA
06/2009 - 06/2008
4Tyrosine Kinase InhibitorsIBA
01/2023 - 01/2021
3Messenger RNA (mRNA)IBA
10/2017 - 03/2006
3DNA (Deoxyribonucleic Acid)IBA
01/2017 - 09/2010
3SurvivinIBA
03/2010 - 11/2003
3Troglitazone (Rezulin)FDA Link
09/2008 - 06/2008
2PlatinumIBA
02/2024 - 01/2020
2Etoposide (VP 16)FDA LinkGeneric
02/2024 - 09/2009
2Programmed Cell Death 1 ReceptorIBA
08/2023 - 01/2023
2Bevacizumab (Avastin)FDA Link
01/2023 - 07/2022
2ErbB Receptors (EGF Receptor)IBA
01/2023 - 01/2021
2Proliferating Cell Nuclear Antigen (PCNA)IBA
11/2020 - 09/2009
2Phosphotransferases (Kinase)IBA
10/2017 - 09/2006
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2017 - 03/2006
2Cadherins (E-Cadherin)IBA
01/2011 - 09/2008
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2010 - 09/2009
2Caspase 3 (Caspase-3)IBA
03/2010 - 09/2009
2Therapeutic UsesIBA
09/2009 - 02/2005
2Interferon Regulatory Factor-1 (Interferon Regulatory Factor 1)IBA
02/2009 - 03/2006
2Rosiglitazone (Avandia)FDA Link
01/2009 - 06/2008
2InterferonsIBA
02/2008 - 03/2006
1Indicators and Reagents (Reagents)IBA
01/2024
1Retinaldehyde (Retinal)IBA
09/2023
1sintilimabIBA
08/2023
1Neoplasm Antigens (Tumor Antigens)IBA
08/2023
1LipopolysaccharidesIBA
06/2023
1tectorigeninIBA
06/2023
1130-nm albumin-bound paclitaxelIBA
06/2023
1ginsenoside Rg3IBA
02/2023
1InflammasomesIBA
02/2023
1brigatinibIBA
01/2023
1Anaplastic Lymphoma KinaseIBA
01/2023
1B7-H1 AntigenIBA
01/2023
1LuciferasesIBA
04/2022
1RNA Precursors (Precursor, mRNA)IBA
04/2022
1Competitive Endogenous RNAIBA
04/2022
1Circular RNAIBA
04/2022
1Purinergic Receptors (Receptors, Purine)IBA
01/2022
1tryptamine N-methyltransferase (amine N-methyltransferase)IBA
01/2022
1anlotinibIBA
01/2022
1CateninsIBA
01/2021
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2021
1Cytochrome P-450 CYP2C19IBA
01/2021
1Methotrexate (Mexate)FDA LinkGeneric
11/2020

Therapy/Procedure

8Radiotherapy
02/2024 - 07/2019
7Immunotherapy
02/2024 - 01/2021
7Therapeutics
02/2024 - 01/2009
6Drug Therapy (Chemotherapy)
02/2024 - 07/2019
2Cranial Irradiation
06/2023 - 01/2018
2Chemoradiotherapy
05/2023 - 07/2019
1Lymph Node Excision (Lymph Node Dissection)
01/2024
1Orchiectomy (Orchidectomy)
01/2024
1Lithotripsy (Extracorporeal Shockwave Lithotripsy)
04/2021